Skip to main content
SpringerLink
Log in

Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Four hundred and sixty patients with stage II or III breast cancer following regional therapy were treated with an adjuvant combination chemotherapy consisting of fluorouracil, doxorubicin, and cyclophosphamide (FAC). The relationship between the length of disease-free survival and length of delays in initiation of chemotherapy after surgery was evaluated. Patients were divided into four subgroups according to the length of delay in initiation of chemotherapy (< 10 weeks, 10–13, 14–17, and ≥ 18 weeks). Overall four year diseasefree survival was 64%, 68%, 60%, and 63% for patient groups with delays of < 10 weeks, 10–13, 14–17, or ≥ 18 weeks respectively (p = 0.39). There was no trend for longer delay in treatment to be associated with shorter disease-free survival, except in poor prognosis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schabel FM: Experimental basis of adjuvant chemotherapy.In SE Salmon and SE Jones (eds): Adjuvant Therapy of Cancer. Elsevier/North-Holland Biomedical Press, Amsterdam, 1977, p 3–14

    Google Scholar 

  2. Goldie JH, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733, 1979

    PubMed  Google Scholar 

  3. Blumenschein G, Buzdar A, Hortobagyi G, Yap H: Adjuvant chemo-immunotherapy of regionally treated stage IV breast cancer patients: A five year follow-up.In SE Salmon and SE Jones (eds): Adjuvant Therapy of Cancer III. Grune and Stratton, New York, 1981, pp 427–434

    Google Scholar 

  4. Bonadonna G, Valagussa P: Dose response effect of adjuvant chemotherapy in breast cancer. New Engl J Med 304: 10–15, 1981

    PubMed  Google Scholar 

  5. Buzdar AU, Gutterman JU, Blumenschein GR, Hortobagyi GN, Tashima CK, Montague E, Hersch EM, Freireich EJ, Gehan E: Intensive post-operative chemotherapy in patients with stage II and III breast cancer. Cancer 41: 1064–1076, 1978

    PubMed  Google Scholar 

  6. Buzdar A, Smith T, Blumenschein G, Hortobagyi G, Hersh E, Gehan E: Adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC) for stage II or III breast cancer: 5-year results.In SE Salmon and SE Jones (eds): Adjuvant Therapy of Cancer III. Grune & Stratton, New York, 1981, pp 419–426

    Google Scholar 

  7. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrika 52: 203–223, 1965

    PubMed  Google Scholar 

  8. Breslow N: A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57: 579–594, 1970

    Google Scholar 

  9. Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norin T: Surgical adjuvant chemotherapy results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 41: 2088–2098, 1978

    PubMed  Google Scholar 

  10. Cooper RG, Holland JF, Glidewell O: Adjuvant chemotherapy of breast cancer. Cancer 44: 793–798, 1979

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Breast Service-Department of Medicine, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, 6723 Bertner Avenue, 77030, Houston, Texas, USA

    Aman U. Buzdar M.D., Kimberly C. Powell R.N. & George R. Blumenschein M.D.

  2. Department of Biomathematics, The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, Texas, USA

    Terry L. Smith B.S. & Edmund A. Gehan Ph.D.

Authors
  1. Aman U. Buzdar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry L. Smith B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kimberly C. Powell R.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George R. Blumenschein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Edmund A. Gehan Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buzdar, A.U., Smith, T.L., Powell, K.C. et al. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Tr 2, 163–169 (1982). https://doi.org/10.1007/BF01806452

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806452

Keywords

Search

Navigation